FDA Clears Nexstim’s New Module for Use With NBS System

Nexstim Oy announced that the FDA has cleared the NexSpeech module for use with the Navigated Brain Stimulation (NBS) system. In presurgical planning for patients with brain tumors, the NBS System enables accurate and reliable mapping of the vital motor areas in the brain.
News Medical